Agios Pharmaceuticals (AGIO) Amortizatization of Intangibles (2012 - 2026)

Agios Pharmaceuticals (AGIO) has 15 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q2 2026.

• Quarterly Amortizatization of Intangibles fell 53.43% year-over-year to $1.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.7 million (down 56.56% YoY) and the FY2025 annual result came in at $7.2 million, down 50.33% from the prior year.
• Amortizatization of Intangibles retreated to $1.1 million in Q2 2026, from $1.1 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $5.6 million in Q4 2024 to a low of -$1.2 million in Q1 2022.
• A 5-year average of $1.7 million and a median of $1.7 million in 2025 frame the typical range for Amortizatization of Intangibles.
• The widest YoY moves for Amortizatization of Intangibles: up 1376.72% in 2023, down 263.39% in 2023.
• Tracing AGIO's Amortizatization of Intangibles over 5 years: stood at $1.9 million in 2022, then tumbled by 79.52% to $393000.0 in 2023, then surged by 1329.01% to $5.6 million in 2024, then slumped by 68.79% to $1.8 million in 2025, then plunged by 35.71% to $1.1 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.1 million (Q2 2026), $1.1 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.